NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PAGE Therapeutics AG

PAGE Therapeutics AG

Private
BaselHealthcare & Life Scienceshttps://pagetherapeutics.com/

Last Round

Seed

Oct 25, 2024

Company Overview

PAGE Therapeutics AG is a biotechnology company that operates a platform for oncology drug development intended to discover and commercialize anti-metastatic compounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oncologycirculating tumor cellCTCmetastasis preventionanti-metastatic therapydrug discoverysmall moleculebiotechNa+/K+ ATPase inhibitorpreclinical researchcancer researchdrug licensingsolid tumor therapycancer drug startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PAGE Therapeutics AG Comparables

Compare PAGE Therapeutics AG with similar companies based on industry and business-model similarity.

PAGE Therapeutics AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZielBio
64%
Novartis
62%
Boehringer Ingelheim
62%

PAGE Therapeutics AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 25, 2024
Early FundingMay 11, 2023
SeedMar 1, 2023

Key People

Founding team and executive leadership

Daniele Scarinci

Acting CEO

Executive Team

PAGE Therapeutics AG Investors

Notable investors and investment history

PAGE Therapeutics AG investors
InvestorRounds
ETH ZurichEarly Funding, Seed
XGEN VentureEarly Funding, Seed
Kizoo Technology CapitalSeed, Early Funding
Claris VenturesSeed, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2023

    Seed round raised with participation from Claris Ventures and Kizoo Technology Capital.

PAGE Therapeutics AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PAGE Therapeutics AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PAGE Therapeutics AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range6
Year Founded2022
Last FundingOct 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.